Navigation

Breast cancer - trastuzumab

The clinical effectiveness and cost effectiveness of trastuzumab for breast cancer

Status: History
Expected date of issue: March 2002
Process: MTA
Description:

This appraisal commenced prior to the 6th February 2001 and is being appraised under the Institute's old appraisal process. Therefore documentation on the scope, the assessment report protocol and the provisional appraisal determination will be not available. However, below are some of the key dates and contact details relating to this appraisal. Once the Institute has issued guidance on this topic, the full guidance, patient information, health technology assessment report and press release will be made available on the website.

Topic area:
 

NICE project team

Executive Lead: Anne-Toni Rodgers
Technical Lead: Dr Alec Miners
Communications manager: Julian Lewis
Project manager: Kathleen Dalby
Assessment Group / Evidence Review Group: NHS Centre for Reviews and Dissemination, University of York
Top


 

Provisional schedule

1st appraisal committee meeting: 20 March 2001
2nd appraisal committee meeting: 25 October 2001
3rd appraisal committee meeting: 22 January 2002
Top


 

Consultees and commentators

Consultees Commentators (no right of appeal)
Manufacturers / Sponsors
  • Breakthrough Breast Cancer
  • Breast Cancer Care
  • British Psychosocial Oncology Society (BPOS)
  • Cancer BACUP
  • Cancer Care Society
  • Cancerlink
  • Department of Health
  • Department of Health
  • Imperial Cancer Research Fund
  • Institute of Health Care Management
  • Macmillan Cancer Relief
  • MRC Clinical Trials Unit
  • National Assembly for Wales
  • National Cancer Alliance
  • National Cancer Research Institute
  • National Council for Hospice and Specialist Palliative Care Services
  • Roche
  • Royal College of General Practitioners
  • Royal College of Nursing Institute
  • Royal College of Paediatrics & Child Health
  • Royal College of Pathologists
  • Royal College of Physicians
  • Teenage Cancer Trust
  • The Cancer Research Campaign
  • UK Breast Cancer Coalition
Patient / Carer Groups
  • None
Professional Groups
  • None
Others
  • None

 

General
  • None
Comparator Manufacturers
  • None
Assessment Team
  • None
Associated Guideline Groups
  • None
Associated Public Health Groups
  • None
Research Groups
  • None

 

Top


 

Project history

Acting on feedback recieved from consultees during the consultation on the provisional appraisal determination the Appraisal Committe recommended that the Assessment Report this appraisal should be extended, in order to consider additional clinical data.

The Appraisal Committee met to reconsider the evidence at its meeting in October 2001 and produced a revised provisional determination for consultation.

Top


 

Key documents

This page was last updated: 30 March 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.